Phellodendrine Chloride Modulates IL-6/STAT3 in Gouty Arthri
2026-06-11
This study demonstrates that phellodendrine chloride, a bioactive alkaloid from Phellodendron chinense, alleviates monosodium urate crystal-induced gouty arthritis by inhibiting the IL-6/STAT3 signaling pathway. The findings reveal a reduction in inflammation and cartilage degradation, presenting a potential alternative therapeutic avenue for gout management with fewer side effects than standard treatments.
Ivermectin as a Broad-Spectrum Anti-Parasitic: Experimental
2026-06-11
Explore the scientific depth of Ivermectin as a broad-spectrum anti-parasitic, emphasizing cutting-edge research, protocol optimization, and translational relevance. This article uniquely bridges mechanistic insights with innovative experimental strategy, setting it apart from previous overviews.
Gepotidacin: Strategic Insights for Translational Antibacter
2026-06-10
This thought-leadership article explores Gepotidacin’s mechanistic innovation as a dual bacterial topoisomerase inhibitor, its experimental and translational value in the context of rising antibiotic resistance, and how researchers can strategically leverage this compound for impactful antibacterial and resistance research. Integrating clinical, mechanistic, and workflow perspectives, the article provides actionable guidance and protocol parameters while positioning Gepotidacin within APExBIO’s research ecosystem.
Ivermectin (SKU A2813): Reliable Anti-Parasitic Research Sol
2026-06-10
This scenario-driven guide addresses key laboratory challenges faced in cell viability and parasitology research, showing how Ivermectin (SKU A2813) from APExBIO ensures reproducibility and data integrity. The article provides actionable, evidence-based recommendations for experimental design, protocol optimization, and product selection, emphasizing the compound's proven purity, solubility, and workflow compatibility.
Dihydrotestosterone (DHT) for AR Signaling and Disease Model
2026-06-09
Dihydrotestosterone (DHT) is a potent tool for dissecting androgen receptor signaling, EGFR pathway modulation, and translational disease models. Here, we translate recent breakthroughs and detailed workflows into actionable guidance, with troubleshooting tips to maximize experimental success using APExBIO’s DHT.
Nonconventional Agonist-Antagonist Dynamics at the GLP-1 Rec
2026-06-09
This study reveals that glucagon can act as a nonconventional agonist at the GLP-1 receptor, with antagonism by classical and non-classical inhibitors demonstrated using high-throughput FRET cAMP assays. These findings challenge existing views on receptor selectivity and inform the design of metabolic regulation studies and peptide-based therapies.
Romidepsin (FK228): Selective HDAC Inhibitor for Cancer Epig
2026-06-08
Romidepsin (FK228) is a potent, selective class I histone deacetylase inhibitor used in cancer epigenetics research. It targets HDAC1/2 with nanomolar IC50 values, modulates chromatin, and synergizes with PARP inhibition in hepatocellular carcinoma models.
Machine Learning-Powered Prediction of LNPs for mRNA Vaccine
2026-06-08
This study pioneers a machine learning approach to predict and optimize lipid nanoparticle (LNP) formulations for mRNA vaccine delivery. By integrating computational modeling with experimental validation, it highlights the critical role of ionizable cationic liposomes such as Dlin-MC3-DMA in achieving high in vivo efficacy and sets new standards for rapid, data-driven LNP design.
Plant-Based Molluscicides: Efficacy of H. abyssinica Against
2026-06-07
The reference study rigorously evaluates the molluscicidal properties of extracts from Hagenia abyssinica, Rosa abyssinica, and Cucumis ficifolius against key schistosomiasis snail vectors. H. abyssinica demonstrated potent activity, with favorable selectivity and acute toxicity profiles, suggesting its promise for integrated snail control in endemic settings.
Distinct DNA Cleavage by Gepotidacin: Insights for Gyrase In
2026-06-06
Gibson et al. reveal that gepotidacin inhibits Staphylococcus aureus DNA gyrase via a unique single-stranded DNA cleavage mechanism, contrasting the double-stranded breaks typically induced by fluoroquinolones. These findings reshape our understanding of DNA gyrase inhibition and inform future antibiotic and toxicity research.
K+ Channel Blockade and Renal Blood Flow in Septic Rat Model
2026-06-05
This study investigates the impact of ATP-sensitive and calcium-activated potassium channel blockade on renal blood flow in septic rats, revealing that K+ channel dysfunction and pharmacological inhibition can exacerbate reductions in renal perfusion when combined with vasoactive agents. The findings highlight the complex interplay between vascular potassium channels and the hemodynamic response in sepsis, with direct implications for research strategies in vascular biology and renal pathophysiology.
Tofacitinib Citrate (CP-690550): Precision Tools for JAK3 Re
2026-06-05
Explore the molecular precision of Tofacitinib citrate (CP-690550 citrate) in immune regulation research. This article delivers new assay insights and critical safety considerations, bridging advanced JAK-STAT pathway analysis with practical experimental design.
Dimethyloxalylglycine (DMOG): Technical Use and Protocols
2026-06-04
Dimethyloxalylglycine (DMOG) provides a reliable approach for stabilizing hypoxia-inducible factor (HIF-1α) in controlled research settings, enabling precise study of hypoxia signaling and inflammation. It is strictly intended for preclinical laboratory applications and should not be used for diagnostic or clinical purposes.
EGLN3's Role in Pulmonary Vascular Remodeling and Endothelia
2026-06-04
Deng et al. uncover the mechanistic role of EGLN3 in pulmonary hypertension, showing that its hypoxia-driven upregulation in endothelial cells drives vascular remodeling and dysfunction. Their findings reveal a JUN–EGLN3–HUR–EGFR axis that promotes endothelial proliferation and migration, highlighting EGLN3 as a promising therapeutic target.
Cefazedone (Refosporen): Translational Pharmacology and Clin
2026-06-03
Explore how Cefazedone (Refosporen), a first-generation cephalosporin, bridges advanced in vitro pharmacology with real-world clinical efficacy. This article delivers unique protocol guidance and practical insights for researchers and clinicians.
467 records 16/32 page Previous Next First page 上5页 1617181920 下5页 Last page